Showing 1,181 - 1,200 results of 227,974 for search '(( 5 ((ppm decrease) OR (mean decrease)) ) OR ( a ((fold decrease) OR (a decrease)) ))', query time: 1.71s Refine Results
  1. 1181
  2. 1182

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC<sub>(tofacitinib, 0–∞)</sub> and a 9.61-fold increase of colonic AUC<sub>(tofacitinib, 0–12h)</sub>, compared with tofacitinib at a molar equivalent oral dose. …”
  3. 1183

    Phospho-ERK level is decreased in 3D spheroids. by Keven Huang (675616)

    Published 2014
    “…(<b>B</b>) Corresponding normalized pERK levels showed a strong correlation between increasing CXCR4 surface expression with decreasing phospho-ERK levels. (*, P <0.05 vs Adh, 1-way ANOVA) (***, P <0.0001 vs Adh, 1-way ANOVA). …”
  4. 1184

    CM-DWM-EC chart using 30% decrease in the mean for the E(KeV). by Shumaila Nisar (20114256)

    Published 2024
    “…<p>CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).</p>…”
  5. 1185
  6. 1186
  7. 1187
  8. 1188

    SETD2 mediates the binding of MALAT1 and pSmads. by Jinqiang Zhang (709289)

    Published 2020
    “…<b>D,</b> Smad2 linker region mutations decrease its capability to form protein complex with PPM1A and SETD2 proteins. …”
  9. 1189
  10. 1190
  11. 1191
  12. 1192
  13. 1193
  14. 1194
  15. 1195
  16. 1196
  17. 1197
  18. 1198
  19. 1199
  20. 1200

    Decrease of renal fibrosis during AT1 receptor antagonism. by Anne-Cécile Huby (5653777)

    Published 2013
    “…Values are are mean±SEM; n = 5, 9 and 13 for wild type and RenTg mice before and after irbesartan, respectively; ** P<0,01 vs WT; <sup>##</sup> P<0,01 vs RenTg. …”